US Stock MarketDetailed Quotes

SANA Sana Biotechnology

Watchlist
  • 1.705
  • +0.055+3.33%
Trading Jan 3 10:19 ET
380.67MMarket Cap-1.22P/E (TTM)

About Sana Biotechnology Company

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Company Profile

SymbolSANA
Company NameSana Biotechnology
Listing DateFeb 4, 2021
Issue Price25.00
Founded2018
CEODr. Steven D. Harr, M.D.
MarketNASDAQ
Employees328
Fiscal Year Ends12-31
Address188 East Blaine Street,Suite 400
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98102
Phone1-206-701-7914

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Steven D. Harr, M.D.
  • President, Acting Principal Financial Officer, Chief Executive Officer and Director
  • 2.67M
  • Susan Wyrick
  • Acting Chief Financial Officer, Acting Treasurer, and Acting Principal Accounting Officer
  • --
  • Christian Hordo
  • Executive Vice President and Chief Business Officer
  • --
  • Bernard J. Cassidy
  • Executive Vice President, General Counsel and Corporate Secretary
  • --
  • Hans Edgar Bishop
  • Chairman of the Board
  • 354.80K
  • Dr. Richard C. Mulligan, PhD
  • Executive Vice Chairman of the Board
  • --
  • Dr. Patrick Y. Yang, PhD
  • Independent Director
  • 299.80K
  • Dr. Douglas G. Cole, M.D.
  • Independent Director
  • 302.30K
  • Dr. Joshua H. Bilenker, M.D.
  • Independent Director
  • 299.80K
  • Robert Taylor Nelsen
  • Independent Director
  • 294.80K
  • Dr. Alise S. Reicin, M.D.
  • Independent Director
  • 302.30K
  • Michelle Seitz, C.F.A.
  • Independent Director
  • 314.80K
  • Mary Agnes Wilderotter
  • Independent Director
  • 314.80K
Heat List
US
Overall
Symbol
Price
% Chg

No Data